Retraction Note: Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial
- PMID: 32576162
- PMCID: PMC7310420
- DOI: 10.1186/s12886-020-01524-8
Retraction Note: Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial
Abstract
An amendment to this paper has been published and can be accessed via the original article.
Retraction of
-
Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial.BMC Ophthalmol. 2019 Jun 17;19(1):131. doi: 10.1186/s12886-019-1136-8. BMC Ophthalmol. 2019. Retraction in: BMC Ophthalmol. 2020 Jun 23;20(1):251. doi: 10.1186/s12886-020-01524-8. PMID: 31208393 Free PMC article. Retracted. Clinical Trial.
Similar articles
-
Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial.BMC Ophthalmol. 2019 Jun 17;19(1):131. doi: 10.1186/s12886-019-1136-8. BMC Ophthalmol. 2019. Retraction in: BMC Ophthalmol. 2020 Jun 23;20(1):251. doi: 10.1186/s12886-020-01524-8. PMID: 31208393 Free PMC article. Retracted. Clinical Trial.
-
Effectiveness and Optical Quality of Topical 3.0% Diquafosol versus 0.05% Cyclosporine A in Dry Eye Patients following Cataract Surgery.J Ophthalmol. 2016;2016:8150757. doi: 10.1155/2016/8150757. Epub 2016 Feb 16. J Ophthalmol. 2016. PMID: 26989503 Free PMC article.
-
Tear volume estimation using a modified Schirmer test: a randomized, multicenter, double-blind trial comparing 3% diquafosol ophthalmic solution and artificial tears in dry eye patients.Clin Ophthalmol. 2016 May 13;10:879-86. doi: 10.2147/OPTH.S105275. eCollection 2016. Clin Ophthalmol. 2016. PMID: 27257372 Free PMC article.
-
Diquafosol ophthalmic solution 3 %: a review of its use in dry eye.Drugs. 2015 May;75(8):911-22. doi: 10.1007/s40265-015-0409-7. Drugs. 2015. PMID: 25968930 Review.
-
Pharmacokinetic evaluation of diquafosol tetrasodium for the treatment of Sjögren's syndrome.Expert Opin Drug Metab Toxicol. 2014 Jun;10(6):905-13. doi: 10.1517/17425255.2014.915026. Epub 2014 May 6. Expert Opin Drug Metab Toxicol. 2014. PMID: 24797483 Review.
References
Publication types
LinkOut - more resources
Full Text Sources